Akt targeting as a strategy to boost chemotherapy efficacy in non-small cell lung cancer through metabolism suppression-Reference-Cited by-同舟云学术

Akt targeting as a strategy to boost chemotherapy efficacy in non-small cell lung cancer through metabolism suppression

Published:2017-03-23 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Le Grand Marion,Berges Raphael,Pasquier Eddy,Montero Marie-Pierre,Borge Laurence,Carrier Alice,Vasseur Sophie,Bourgarel Veronique,Buric Duje,André Nicolas,Braguer Diane,Carré Manon

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep45136.pdf

Reference45 articles.

1. Torre, L. A. et al. Global cancer statistics. Cancer J. Clin. 65, 87–108 (2015).

2. Aisner, D. L. & Marshall, C. B. Molecular pathology of non-small cell lung cancer: a practical guide. Am. J. Clin. Pathol 138, 332–346 (2012).

3. Peters, S. et al. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. ESMO 23 Suppl 7, vii56–64 (2012).

4. Steuer, C. E. & Ramalingam, S. S. Targeting EGFR in lung cancer: Lessons learned and future perspectives. Mol. Aspects Med. 45, 67–73 (2015).

5. Muñoz-Pinedo, C., El Mjiyad, N. & Ricci, J. E. Cancer metabolism: current perspectives and future directions. Cell Death Dis. 3, e248 (2012).

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAVPENET Peptide Inhibits Prostate Cancer Cells Proliferation and Migration through PP1γ-Dependent Inhibition of AKT Signaling;Pharmaceutics;2024-09-12

2. Augmented drug combination dataset to improve the performance of machine learning models predicting synergistic anticancer effects;Scientific Reports;2024-01-18

3. Augmented drug combination dataset to improve the performance of machine learning models predicting synergistic anticancer effects;2023-10-28

4. Recent advances in non-small cell lung cancer targeted therapy; an update review;Cancer Cell International;2023-08-11

5. Targeting glycolysis in non-small cell lung cancer: Promises and challenges;Frontiers in Pharmacology;2022-11-30